Search results
Diagnosing Psoriatic Arthritis for the Dermatologist
Medscape· 1 week agoEditor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...
Remicade and interactions: Other drugs, alcohol, and more
Medical News Today· 2 weeks agoBefore you start treatment with Remicade, tell your doctor and pharmacist which prescription,...
Rinvoq interactions: Other medications, alcohol, and more
Medical News Today· 1 week agoRinvoq (upadacitinib) is a brand-name extended-release oral tablet prescribed for certain autoimmune...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 11 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 6 days agoData from the SURMOUNT-OSA studies showed that treatment with tirzepatide resulted in a mean AHI...
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant...
NBC 17 Raleigh· 1 week ago...who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen achieved sustained remission from week 12 through week 52 compared to 29 percent of patients receiving placebo with a 52-week steroid taper regimen1− The safety profile in GCA was generally consistent with...